1-7 of 7
Tiffany N. Tanaka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Randomized Clinical Trial Comparing a Calcineurin-Free Gvhd Prophylaxis Regimen with Post-Transplant Cyclophosphamide and Abatacept to Methotrexate and Tacrolimus

Divya Koura, James Mirocha, Kaitlyn C Dykes, Ayad Hamdan, Aaron Goodman, Tiffany N Tanaka, Carolyn M. Mulroney, Caitlin L. Costello, James K. Mangan, Edward D. Ball, Ah-Reum Jeong, Joseph Maroge, Michelle Padilla, Dimitrios Tzachanis
Journal: Blood
Blood (2023) 142 (Supplement 1): 3551.
https://doi.org/10.1182/blood-2023-173906
Published: 2023
Journal Articles

Phenotypic and Proliferative Analysis of T Cell and Monocyte Populations in Patients with Intermediate/High/Very High-Risk MDS Compared to Age-Matched Healthy Donors

Hannah Fields, Valentina Ferrari, BA, Alison Tarke, BS, Randy Guo-Shi Tsai, BS, BA, Timothy Luger, Colin McCarthy, BS, Ruifeng Chen, Xinlian Zhang, Thomas A Lane, MD, Antonella Vitiello, Dr. Pharm., Rafael Bejar, MD PhD, Tiffany N Tanaka, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-142038
Published: 2020
Journal Articles

T Cell Activation By OKT3 Is a Function of the Percent Monocytes in PBMC of Healthy Donors and MDS Patients

Alison Tarke, Valentina Ferrari, BA, Hannah Fields, Luca Ferrari, Franco Ferrari, PhD, Tiffany N Tanaka, MD, Rafael Bejar, MD PhD, Antonella Vitiello, Dr. Pharm., Thomas A Lane, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4870.
https://doi.org/10.1182/blood-2019-131474
Published: 2019
Journal Articles

MDS overlap disorders and diagnostic boundaries

Clinical Trials & Observations
Tiffany N. Tanaka, Rafael Bejar
Journal: Blood
Blood (2019) 133 (10): 1086–1095.
https://doi.org/10.1182/blood-2018-10-844670
Published: 2019
Journal Articles

A Phase 1 Clinical Trial of Personalized Adoptive Cellular Therapy Targeting Myelodysplastic Syndrome (MDS) Stem Cell Neoantigens (PACTN)

Valentina Ferrari, Tiffany N Tanaka, MD, Alison Tarke, Hanna Fields, Luca Ferrari, Alex Ni, Franco Ferrari, PhD, John Warner, PhD, Theresa Jochelson, Rafael Bejar, MD PhD, Antonella Vitiello, Dr. Pharm., Thomas A Lane, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4373.
https://doi.org/10.1182/blood-2018-99-118834
Published: 2018
Journal Articles

DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of MDS

Brian M Reilly, BS, Tiffany N Tanaka, MD, Dinh Diep, PhD, Huwate Yeerna, BS, Pablo Tamayo, PhD, Kun Zhang, PhD, Rafael Bejar, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 106.
https://doi.org/10.1182/blood-2018-99-111535
Published: 2018
Journal Articles

Methylation Profiling Among Patients with TET2 Mutations in Myelodysplastic Syndromes Is Associated with Overall Survival

Tiffany N Tanaka, MD, Brian Reilly, BS, Dinh Diep, BS, Kun Zhang, PhD, Rafael Bejar, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3158.
https://doi.org/10.1182/blood.V128.22.3158.3158
Published: 2016